Dr. David F Claxton MD
Hematologist-Oncologist | Hematology & Oncology
500 University Dr Hershey PA, 17033About
Dr. David Claxton is a hematologist oncologist practicing in Hershey, PA. Dr. Claxton specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Mc Gill Univ- Fac Of Med- Montreal- Que- Canada 1978
McGill University Faculty of Medicine 1978
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Therapeutic potential of leukemia-derived dendritic cells: preclinical and clinical progress.
- Retinoids and cancer therapy.
- Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation.
- Epigenetic heterochromatin markers distinguish terminally differentiated leukocytes from incompletely differentiated leukemia cells in human blood.
- Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions.
- Sirolimus in unmanipulated haploidentical cell transplantation.
- Oral administration of analgesia and anxiolysis for pain associated with bone marrow biopsy.
- SIRS criteria in prediction of septic shock in hospitalized patients with hematologic malignancies.
- A non-coding cationic lipid DNA complex produces lasting anti-leukemic effects.
- Out foxing bcr-abl.
- Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for in vivo photodynamic therapy of leukemia.
- Calcium phosphosilicate nanoparticles for imaging and photodynamic therapy of cancer.
- Tyrosine kinase targeted treatment of chronic myelogenous leukemia and other myeloproliferative neoplasms.
- Phase I/II study of clofarabine, etoposide, and mitoxantrone in patients with refractory or relapsed acute leukemia.
- Extracts of Devil's club (Oplopanax horridus) exert therapeutic efficacy in experimental models of acute myeloid leukemia.
Clinical Trials
Treatments
- Anemia
- Acute Myeloid Leukemia (aml)
- Lymphoma
- Leukemia
- Dermal Aesthetics
- Oral Surgery Procedures
- Extra Corporeal Shockwave Therapy
Dr. David F Claxton MD's Practice location
Hershey, PA 17033Get Direction
Dr. David F Claxton MD's reviews
Write ReviewPatient Experience with Dr. Claxton
Recommended Articles
- The Blow Self-Image Can Take During Lymphoma Treatment
Many who have endured cancer treatment experience a blow to their self image, and cease to recognize the person looking back at them in the mirror.However, it does not have to be that way! Here are some of the most common changes, and how to cope with them.Skin changesYou may begin to see your skin...
- How This Survivor Star Beat Hodgkin Lymphoma—Twice
Ethan Zohn is a survivor in many ways. In 2002, he outlasted 15 fiercely strong competitors on the popular TV show, Survivor: Africa. His strength, wit, athleticism, and perseverance won him a million-dollar prize after he defeated these opponents. However, his victory was short-lived. Little did he...
- Little Boy Tugs at Heartstrings of Entire Community: Be the Match!
Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...
- New Study Discovers How Lymphoma Affects Survivors’ Ability to Work
Young adults in many countries pride themselves on their work. They have worked hard to get to where they are and there is a huge sense of accomplishment in joining the adult world and being able to provide for themselves and their new families if applicable. When cancer comes along, their ability...
- Living with Lymphoma Day by Day
A majority of individuals diagnosed with lymphoma find that they have to make a great deal of adjustments to their lives. There are several physical, emotional, social, and everyday obstacles from diagnosis to remission.Living with lymphoma can be different for every individual, which is why it is...
- Genetic Advancements in Lymphoma Treatment
Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...
Nearby Providers
- Charles W. Reninger, III.101 Erford Road Camphill Pennsylvania 17011
- Dr. Hyatt Peter DeGreen D.O.500 University Dr Hershey PA 17033
- Dr. Elliot Mark Epner MD500 University Dr Hershey PA 17033
- Dr. Jeffrey J. Pu M.D.500 University Dr Hershey PA 17033
- Dr. Chandra P Belani MD500 University Dr Hershey PA 17033
- Dr. Cristina I Truica M.D.500 University Dr Hershey PA 17033